Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Protalix BioTherapeutics (PLX) sets 2026 director, pay and stock plan votes
Protalix BioTherapeutics (PLX) has announced its 2026 annual stockholder meeting to be held on June 25, 2026, in Tel Aviv. Key agenda items include the election of eight directors, a non-binding advisory vote on executive compensation, and the approval of an amended 2006 Stock Incentive Plan to increase the share reserve by 3.5 million to 20,975,171 shares. The company also reported CEO Dror Bashan’s 2025 compensation of $1.17 million and outlined change-in-control benefits for executives.